Home Authors Posts by Christopher Faille

Christopher Faille

Wellcome Trust medical research endowment DNA
The firm's first special situations strategy focused on biotech companies raises $85m.
Ares fundraising target
Vehicle beats its target, and a new commentary by Oaktree may throw some unintended light on its strategy.
Asset-backed, income opportunities product spans real assets, specialty finance and aviation.
Purchase of one of the largest European credit managers brings the AUM of FT's alternative strategies to $260bn.
Despite concerns about economic recession and high inflation, consumer credit continues to be robust.
Recent judicial decisions and bankruptcy filings address unsettled questions of importance to creditor funds with portfolio companies in Chapter 11. Christopher Faille reports
Purchase will add to GA’s ‘experience in public and private credit strategies'.
Pennsylvania headquartered asset manager
Third fund on the platform is a senior credit opps vehicle offering flexibility and low minimum investments.
Second vintage focused on distressed assets doubles that of precursor and exceeds target of $4bn.
The global alternative asset firm looks to manage up to $60bn of the global insurer's portfolio within six years.
pdi
pdi

Copyright PEI Media

Not for publication, email or dissemination